文献速递间质性肺疾病

肺纤维化无症状一级亲属遗传与临床筛查的心理影响

Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals.
PubMed 文献 · Thorax · 2021-01-22

本研究评估肺纤维化患者无症状一级亲属接受筛查后的心理影响,采用决策后悔量表和基因组检测结果感受问卷在获知结果后测量。超过90%的亲属报告无或轻度决策后悔,但一氧化碳弥散功能低或存在间质性肺异常者后悔与负面感受增加,端粒长度和基因检测结果未显著影响后悔。

要点

  • 超过90%的肺纤维化患者一级亲属筛查后无或仅轻度决策后悔。
  • 弥散功能低或间质性肺异常者决策后悔与负面感受增加。
  • 端粒长度和基因检测结果未显著影响决策后悔。

核心结论

  • 肺纤维化患者无症状一级亲属筛查后多数无或仅轻度决策后悔。
  • 弥散功能低或间质性肺异常与决策后悔和负面感受增加相关。
  • 端粒长度和基因检测结果未显著影响决策后悔。

研究设计与样本

  • 对肺纤维化患者未确诊的一级亲属进行筛查,并在获知结果后施用两种经验证量表评估心理影响。

主要发现

  • 超过90%的亲属报告无或轻度决策后悔。
  • 一氧化碳弥散功能低或存在间质性肺异常者决策后悔和负面感受增加。
  • 端粒长度和基因检测结果未显著影响决策后悔。

临床怎么用

  • 对肺纤维化患者一级亲属筛查时应关注弥散功能低或间质性肺异常者的心理反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Screening for pulmonary fibrosis may help to identify early stages of the disease. We assessed the psychological impact of screening undiagnosed first-degree relatives of patients with pulmonary fibrosis by administering two validated measures after participants received their results: the Decisional Regret Scale and the Feelings About genomiC Testing Results Questionnaire. More than 90% of relatives reported either no or mild decisional regret. Increased measures of decisional regret and negative feelings were present in those found to have a low diffusion capacity of carbon monoxide or interstitial lung abnormalities. Results of telomere length and genetic testing did not significantly impact regret.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Carmichael N, Martinez Manzano JM, Quesada-Arias LD, et al. Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals. Thorax. 2021. PMID: 33483364. doi:10.1136/thoraxjnl-2020-216244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。